Pain
Conditions
Keywords
Topical Anesthetic, Ethyl Chloride, Pain Reduction, IV cannulation
Brief summary
The purpose of this study is to determine whether or not the pain of IV catheter insertion in the Emergency Department can be reduced significantly with the use of a rapid acting topical anesthetic spray and to determine whether or not healthcare providers who undergo such treatment are likely to endorse its use in their future practice.
Detailed description
We recruited 38 emergency department healthcare providers (doctors, physician assistants, nurses and medics) to receive a total of two separate IV canulations - one in one arm and the other in the other. One IV canulation would be pretreated with Ethyl Chloride topical anesthetic (the study product) and the other would be pre-treated with a placebo (sterile water in an aerosol can). Both the participants and the nurses, PAs and medics who placed the IVs were blinded as to which was the Ethyl Chloride and which was the placebo. After the IVs were placed the participants were asked to rate the pain of IV canulation on a scale of 1 to 10 for each of the pre-treatments, to state which one they believed to be superior in reducing the pain of receiving the IV, to state whether or not they would like the intervention that they rated as superior to be used on themselves and finally how likely they were on a 5 point scale to incorporate the intervention they rated as superior into their future practice.
Interventions
DRUGEthyl Chloride Topical Aerosol Anesthetic
Sprayed on the skin for 5-8 seconds immediately before IV cannulation
Sprayed on the skin for 5-8 seconds immediately before IV cannulation
Sponsors
Brooke Army Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
1. At least 18 years of age 2. A healthcare worker who routinely orders or places IV catheters. 3. Consents to participate in the study.
Exclusion criteria
1. History of hypersensitivity to Ethyl Chloride. 2. Break, or swollen in the skin at the proposed IV site. 3. Pregnancy or lactating female. 4. Recent tattoo in either of the two proposed anatomical areas for IV cannulation. 5. Skin infection in either of the two proposed anatomical areas for IV cannulation. 6. Missing a contralateral limb to place the second IV. 7. Recent trauma to one of the upper extremities or any neuropathic or radicular condition that could affect the participant's perception of pain in the antecubital fossa of each arm. \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain | 1 minute | Ordinal pain scale (1-10) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Preferred product | 1 minute | Categorical selection of preferred product for use on self prior to IV placement |
| Desire to use on self in future | 1 minute | Binary (yes, no) desire to use on self prior to IV placement in future |
| Desire to use on patients in future | 1 minute | Binary (yes, no) desire to use on patients prior to IV placement in future |
| Likelihood to use on patients in future | 1 minute | 5 point likert scale ranging from very unlikely to very likely |
Countries
United States
Outcome results
None listed